X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1773) 1773
Patent (116) 116
Publication (67) 67
Newspaper Article (50) 50
Magazine Article (34) 34
Book Chapter (22) 22
Book Review (10) 10
Book / eBook (8) 8
Conference Proceeding (3) 3
Newsletter (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (608) 608
female (415) 415
male (318) 318
cardiac & cardiovascular systems (276) 276
aged (269) 269
middle aged (255) 255
atrial fibrillation (242) 242
risk factors (209) 209
stroke (197) 197
abridged index medicus (143) 143
adult (139) 139
treatment outcome (136) 136
prevention (130) 130
atrial fibrillation - drug therapy (124) 124
mortality (120) 120
warfarin (119) 119
risk (116) 116
peripheral vascular disease (98) 98
aged, 80 and over (96) 96
chemistry (95) 95
human necessities (95) 95
hygiene (95) 95
medical or veterinary science (95) 95
metallurgy (94) 94
anticoagulants (93) 93
organic chemistry (93) 93
analysis (91) 91
care and treatment (91) 91
follow-up studies (91) 91
cardiac arrhythmia (90) 90
preparations for medical, dental, or toilet purposes (89) 89
stroke - prevention & control (85) 85
medicine, general & internal (84) 84
aspirin (83) 83
heterocyclic compounds (83) 83
physics, multidisciplinary (80) 80
drug therapy (79) 79
physics, particles & fields (79) 79
astronomy & astrophysics (78) 78
atrial fibrillation - complications (77) 77
dabigatran (77) 77
research (76) 76
prospective studies (74) 74
management (72) 72
therapy (72) 72
medical and health sciences (71) 71
medicin och hälsovetenskap (71) 71
oncology (71) 71
prognosis (70) 70
clinical trials (69) 69
breast cancer (67) 67
health aspects (66) 66
anticoagulants - therapeutic use (64) 64
cardiovascular (63) 63
double-blind method (60) 60
breast neoplasms - pathology (58) 58
clinical neurology (57) 57
anticoagulation (56) 56
patients (56) 56
retrospective studies (56) 56
heart failure (55) 55
time factors (55) 55
anti-arrhythmia agents - therapeutic use (51) 51
stroke - etiology (51) 51
incidence (50) 50
stroke - epidemiology (49) 49
warfarin - therapeutic use (49) 49
hemorrhage - chemically induced (48) 48
risk assessment (48) 48
medical research (47) 47
heart attacks (46) 46
fibrillation (45) 45
surgery (45) 45
animals (44) 44
anticoagulants - administration & dosage (44) 44
electrocardiography (44) 44
usage (44) 44
atrial-fibrillation (43) 43
experiment (43) 43
high energy physics - experiment (43) 43
anticoagulants - adverse effects (42) 42
clinical medicine (42) 42
high energy physics (42) 42
randomized controlled trials as topic (42) 42
physics (41) 41
cardiology (40) 40
hemorrhage (40) 40
proportional hazards models (39) 39
warfarin - adverse effects (39) 39
atrial fibrillation - epidemiology (38) 38
atrial fibrillation - mortality (38) 38
cancer (38) 38
heart (38) 38
rivaroxaban (38) 38
trial (38) 38
combined modality therapy (37) 37
aspirin - therapeutic use (36) 36
atrial fibrillation - physiopathology (36) 36
cardiovascular disease (36) 36
kardiologi (36) 36
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2072) 2072
French (37) 37
German (12) 12
Spanish (4) 4
Chinese (3) 3
Portuguese (3) 3
Norwegian (2) 2
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Japanese (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, Oxford history of early modern Europe, ISBN 9780199563715, x, 426
.... It covers the extension across the whole island of English state power, a process often referred to as the Tudor conquest, as well as Ireland's early years as part of the Stuart composite monarchy... 
Great Britain Politics and government | Ireland Politics and government | British | Ireland History | History | early modern history (1500 to 1700) | 1485-1603 | 16th century | Great Britain | Ireland | 1172-1603 | 17th century | Politics and government | Tudor | Stuart | Conflict | Gaelic | Conquest | Reformation | Identity | Culture | Irish question
Book
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 20, pp. 2066 - 2078
A randomized trial enrolled 7554 patients with atrial fibrillation who were at increased risk of stroke but not candidates for vitamin K antagonists.... 
STROKE | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | ORAL ANTICOAGULATION | WARFARIN | ANTITHROMBOTIC THERAPY | THROMBOGENESIS | VASCULAR EVENTS | RISK | ACUTE CORONARY SYNDROMES | PLATELET ACTIVATION | Myocardial Infarction - epidemiology | Follow-Up Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Incidence | Vascular Diseases - mortality | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Embolism - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Ticlopidine - analogs & derivatives | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Evaluation | Complications and side effects | Aspirin | Atrial fibrillation | Clopidogrel | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Medical research | Stroke | Mortality | Data collection | Cardiovascular disease | Acute coronary syndromes | Index Medicus | Abridged Index Medicus | Bioengineering | Life Sciences | Vascular Diseases | Computer Science | Atrial Fibrillation | Vitamin K | Embolism | Ticlopidine | Signal and Image processing | Myocardial Infarction | Platelet Aggregation Inhibitors | Engineering Sciences
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 23, pp. 2191 - 2201
In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a... 
CRYPTOGENIC STROKE | TRIALS | MEDICINE, GENERAL & INTERNAL | DESIGN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | ANTITHROMBOTIC THERAPY | FORAMEN OVALE CLOSURE | ATRIAL-FIBRILLATION | Stroke - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Brain Ischemia - prevention & control | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Embolism - drug therapy | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Prevention | Rivaroxaban | Complications and side effects | Dosage and administration | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Neurosciences | Embolisms | Stenosis | Bleeding | Design | Ischemia | Atherosclerosis | Drug dosages | Research centers | Anticoagulants | Medical research | Stroke | Aspirin | Internal medicine | Research & development--R&D | Thrombosis | Patients | Embolism | Blood clots | Medicine | Neurology | Hospitals | Life Sciences | Human health and pathology | metaanalysis | atrial-fibrillation | foramen ovale closure | antithrombotic therapy | Klinisk medicin | efficacy | warfarin | Clinical Medicine | trials | safety | design | cryptogenic stroke | General & Internal Medicine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 12, pp. 1139 - 1151
Journal Article